This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
ATH Technologies (C)
Simons, Robert L.; Packard, JenniferCase HBS-117015-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: Managing Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109082-EStarting at €5.74
-
ATH Technologies (C) (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S05StrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: La administración de Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S04Knowledge and CommunicationStarting at €5.74
-
Bausch & Lomb, Inc.: Presión para conseguir resultados
Simons, Robert L.; Sapir, Alex C.; Reinbergs, IndraCase HBS-105S08Accounting and ControlBausch & Lomb es objeto de ataques de la prensa y experimenta una fuerte caída de los precios de las acciones cuando se exponen las prácticas de gestión. la fijación de objetivos agresivo, apoyado por las expectativas del mercado financiero, se discute como un precursor de una serie de eventos que se traduce en resultados financieros representados incorrectamente y clientes enojados. Un CEO desafiante se mantiene firme como accionistas exigen su ...Starting at €8.20
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArticle HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Starting at €8.20